LY 233053
LY 233053 is a potent and competitive NMDA-receptor antagonist with anticonvulsant and antiepileptic efficacy[1][2].
Product Specifications
CAS Number
125546-04-5
UNSPSC
12352005
Target
IGluR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ly-233053.html
Solubility
10 mM in DMSO
Smiles
OC([C@@H](NCC1)C[C@@H]1CC2=NN=NN2)=O
Molecular Formula
C8H13N5O2
Molecular Weight
211.22
References & Citations
[1]1.K K Borowicz, et al. Competitive NMDA-receptor antagonists, LY 235959 and LY 233053, enhance the protective efficacy of various antiepileptic drugs against maximal electroshock-induced seizures in mice. Epilepsia. 1996 Jul;37 (7) :618-24. |[2]K P Madden, et al. Efficacy of LY233053, a competitive glutamate antagonist, in experimental central nervous system ischemia. J Neurosurg. 1992 Jan;76 (1) :106-10.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
NMDA Receptor
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RBM15B-7470M 50 µg
Recombinant Mouse RBM15B Protein, His (Fc)-Avi-tagged
Sign In for Pricing
View Details 
CRB1000426-01 0.5 mg
[Cys (Npys) ]-TKD (450-463) - (Protein-Protein Interactions)
Sign In for Pricing
View Details